Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

IMPORTANCE: Immunotherapy checkpoint inhibitors have generated considerable interest because of durable responses in a number of hitherto intractable tumor types. OBJECTIVE: To estimate the percentage of patients with cancer in the United States who are eligible for and respond to checkpoint inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslam, Alyson, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503493/
https://www.ncbi.nlm.nih.gov/pubmed/31050774
http://dx.doi.org/10.1001/jamanetworkopen.2019.2535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503493/
https://www.ncbi.nlm.nih.gov/pubmed/31050774
http://dx.doi.org/10.1001/jamanetworkopen.2019.2535

Ejemplares similares